Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for GeneDx Holdings Corp. (WGSWW:NASDAQ), powered by AI.
GeneDx Holdings Corp. is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for GeneDx Holdings Corp. on Alpha Lenz.
View GeneDx Holdings Corp.'s valuation metrics on Alpha Lenz.
“GeneDx Holdings Corp.'s ROE is -22.1%. Explore profitability and growth together.”
Ask for details →GeneDx Holdings Corp. is a recognized entity in the healthcare sector, primarily focusing on genomic testing and analysis. The company is dedicated to providing clinical genomic solutions that empower healthcare providers with precise and timely genetic information critical for diagnosing rare and complex genetic conditions. GeneDx serves a crucial role in the personalized medicine landscape, offering whole-exome sequencing and other advanced genetic tests. These services significantly impact various segments of the healthcare industry, including pediatrics, neurology, oncology, and cardiology, where precise genetic data can lead to more effective patient outcomes. By harnessing the power of genomics, GeneDx aids clinicians in making informed decisions and tailoring treatments according to individual genetic profiles, thus contributing to the broader efforts in disease prevention, management, and research. Its work in the genomic space highlights its importance in advancing medical knowledge and enhancing the capabilities of healthcare systems globally.
“GeneDx Holdings Corp.'s ROE is -22.1%. Explore profitability and growth together.”
Ask for details →GeneDx Holdings Corp. (ticker: WGSWW) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 1,000 employees.
The current price is $0.006 with a P/E ratio of -x and P/B of -x.
ROE is -22.10% and operating margin is -7.60%. Annual revenue is $305M.